Why Arjo stock moves
Arjo rose, moving well ahead of the market.
Written after the close on ·
Why today
15,984 news analyzed todayArjo rose, moving well ahead of the market.
No company news from that session explains the move.
Over the last five trading days Arjo rose very sharply, a very big move for the stock and one of its largest in the past year.
Earlier this week DNB Carnegie upgraded Arjo to buy, raising its target price, the share price it sees as fair, to 40 kronor, which likely lifted sentiment.
Arjo's shares are also at their highest close of the past year, and the next earnings report is due 28 January 2027.
Today's move of +2.37% was 2.8 times a normal day's 0.8%. OMX Stockholm 30 moved +0.83% on the same day.
Arjo +2.37%OMX Stockholm 30 +0.83%Much stronger than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Arjo.
Arjo earned more than expected in 4 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 4 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 36.68 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of 0.66 SEK (January 28). For the current fiscal year, expected earnings per share changed from 2.01 SEK three months ago to 2.00 SEK now. 2026 estimate: 2.00 SEK. 2027 estimate: 2.53 SEK. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. June 2: Buy about 120 thousand SEK. May 13: Buy about 49 thousand SEK. May 13: Buy about 248 thousand SEK. April 23: Buy about 258 thousand SEK. February 6: Buy about 395 thousand SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −12% and earnings per share −33%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 10.0 bn SEKRevenue 2025: 11.0 bn SEK
What the key figures say about Arjo
The figures connect what Arjo earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 1.23 SEK–1.83 SEK. Peers: Terveystalo 0.45 EUR, COMPASS Pathways -$2.34, BioGaia 3.87 SEK. 2026 estimate: 2.00 SEK (1.89 SEK–2.20 SEK). 2027 estimate: 2.53 SEK (2.24 SEK–2.99 SEK).
What the company sold during the year.
2022–2025: 10.0 bn SEK–11.3 bn SEK. Peers: Terveystalo 1.2 bn EUR, BioGaia 1.7 bn SEK. 2026 estimate: 11.3 bn SEK (11.3 bn SEK–11.4 bn SEK). 2027 estimate: 11.7 bn SEK (11.4 bn SEK–11.9 bn SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: 7.6%–9.1%. Peers: Terveystalo 8.0%, BioGaia 29.4%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 4.5%–6.3%. Peers: Terveystalo 10.4%, COMPASS Pathways −296.5%, BioGaia 32.1%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 19.8–26.0. Peers: Terveystalo 13.8, BioGaia 31.6. 2026 estimate: 18.4. 2027 estimate: 14.5.
What investors pay for each unit the company sells.
2022–2025: 0.79–1.06. Peers: Terveystalo 0.66, BioGaia 7.47. 2026 estimate: 0.88. 2027 estimate: 0.85.
Money paid to shareholders per share, summed by calendar year.
2018–2025: 0.50 SEK–1.15 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 2.2%–3.0%. Peers: Terveystalo 10.3%, COMPASS Pathways 0.0%, BioGaia 1.3%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.25–3.16. Peers: Terveystalo 4.22, BioGaia -1.07.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.17–1.43. Peers: Terveystalo 1.47, COMPASS Pathways 8.58, BioGaia 10.11.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 15.4–22.4.
Cash left after investments, divided by the number of shares.
2022–2025: 0.06 SEK–5.07 SEK. Peers: Terveystalo 0.73 EUR, COMPASS Pathways -$1.25, BioGaia 2.55 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 46.5%–51.2%.
The dividend explained
A dividend is money paid to shareholders. Arjo paid 0.95 SEK per share in the twelve months through November 4, 2026.
On the ex-dividend day, April 23, 2026, Arjo traded without the right to the 0.95 SEK dividend. The price went from 26.74 SEK to 25.26 SEK; including the dividend, the day's change was −2.0%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2018: 0.50 SEK2019: 0.55 SEK2020: 0.65 SEK2021: 0.85 SEK2022: 1.15 SEK2023: 0.85 SEK2024: 0.90 SEK2025: 0.95 SEK2026 so far: 0.95 SEK
What to watch next, and why
The earnings report shows how Arjo's revenue and profit have changed.
- Earnings report
The earnings report shows how Arjo's revenue and profit have changed.
Add to calendar
More about Arjo
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Jonas Cederhage, senior executiveBuyabout 120 thousand SEK
- Jonas Cederhage, senior executiveBuyabout 49 thousand SEK
- Christofer Carlsson, CFOBuyabout 248 thousand SEK
- Ulrika Dellby, board memberBuyabout 258 thousand SEK
- Carl Bennet, board member (closely associated)Buyabout 395 thousand SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Arjo usually moved about 4.0%. On a normal day it moves 0.8%.
+15.59% Why? −2.18% −0.67% −10.46%
10,000 SEK in Arjo bought on December 12, 2017 is worth 17,500 SEK today, with dividends reinvested.
What would 10,000 SEK in Arjo be worth today? →
What would 10,000 SEK in Arjo be worth today?
17,500 SEK
with dividends reinvested, bought on December 12, 2017.
The five biggest days of the journey
· −21.3% · the whole market fell 1.4% the same day · report day
· −15.7% · the whole market rose 0.2% the same day · report day
· +15.6% · the whole market fell 2.5% the same day · report day · Why?
· −12.8% · the whole market rose 0.3% the same day · report day
· −12.7% · the whole market fell 10.6% the same day
Earlier days
+8.78% market −0.11% Arjo rose very sharply over the week while the broader market was roughly flat. Read →
Arjo rose very sharply over the week while the broader market was roughly flat.
The move followed a strong quarterly report, after which analysts raised their earnings forecasts and price targets, the fair value they see for the shares.
DNB Carnegie upgraded Arjo to buy on Monday and set a higher target.
The shares are now near their highest level of the past year.
+4.51% market +0.48% Arjo rose very sharply. Read →
Arjo rose very sharply.
DNB Carnegie upgraded the stock to buy and raised its target price, the share price it sees as fair, to 40 kronor.
The move was very big for Arjo, about five times a normal day, and the stock's highest close of the past year.
Over the last five trading days Arjo also rose clearly, and the market rose clearly too.
The upgrade is the most likely main reason for the jump.
−0.06% market +3.01% Arjo was roughly flat over the week, moving less than the broader Stockholm market, which rose clearly. Read →
Arjo was roughly flat over the week, moving less than the broader Stockholm market, which rose clearly.
Analysts were the main news driver: ABG Sundal Collier raised its price target, the share price it sees as fair, to SEK 40 on Monday and kept its buy rating.
The stock moved in line with the market on the last session, edging slightly lower.
Trading was quieter than usual, and the move was ordinary in size for the stock.
+0.36% market +0.41% Arjo rose slightly, in line with the market. Read →
Arjo rose slightly, in line with the market.
No company news from that session explains it.
Over the last five trading days Arjo rose sharply, moving with OMX Stockholm 30, a big move for the stock.
The Q3 report last week beat profit expectations, with adjusted operating profit well above forecasts, which likely supported the shares.
Next earnings report: 28 January 2027.
+0.36% market +0.33% Arjo rose with the market. Read →
Arjo rose with the market.
Over the last five trading days Arjo rose very sharply, far more than the market, which rose only slightly.
The biggest driver was the Q3 report, published last week, which beat expectations on profit and margins.
Analysts then raised their price targets, meaning the share price they see as fair, which supported the rally.
Next, the market will watch the next earnings report on Thursday 28 January 2027.
−1.52% market +0.96% Arjo fell, moving against a market that rose. Read →
Arjo fell, moving against a market that rose.
Trading was ordinary for Arjo.
No company news from that session explains the fall.
Over the last five trading days, Arjo rose very sharply while the market was roughly flat, a very big move for Arjo.
The Q3 report, published last week, likely drove much of that rise, since the company showed higher profit even though earnings missed expectations.
+4.39% market +0.41% Arjo rose sharply, despite an earnings miss, on analyst target price increases. Read →
Arjo rose sharply, despite an earnings miss, on analyst target price increases.
Arjo moved clearly apart from the market: it rose very sharply while OMX Stockholm 30 rose only slightly.
The main driver was SB1 Markets raising its target price, the share price it sees as fair, to SEK 39, and saying the company could reach the upper end of its growth guidance.
Danske Bank also upgraded Arjo to buy, which adds to the positive sentiment.
Over the last five trading days, Arjo fell sharply in price, while the market also fell sharply, so the stock fell less than the index overall.
+20.24% market −3.67% Arjo rose very sharply over the last five trading days, against a falling market. Read →
Arjo rose very sharply over the last five trading days, against a falling market.
The strongest rise came after its Q3 report, which beat expectations on adjusted operating profit (the profit before one-off items), with sales up 6% organically (excluding currency and acquisitions).
Analysts then lifted their price targets, the share prices they see as fair, and Danske Bank upgraded the stock to buy.
The move was very big for Arjo, rare in the past year.
+15.59% market −2.51% Arjo rose sharply after beating expectations on its third-quarter report, though the market fell. Read →
Arjo rose sharply after beating expectations on its third-quarter report, though the market fell.
Arjo's shares rose very sharply in the last session, while the OMX Stockholm 30 fell sharply, so the stock moved against the market.
The move was very big for Arjo, rarer than any move in the past year.
Trading was heavy, well above its usual level.
The main driver was the quarterly report, published in the last session, where adjusted operating profit came in well above forecasts and gross margin, the share of sales left after production costs, widened.
Learn more · Why do stocks go up and down?